ClinVar Genomic variation as it relates to human health
NM_057175.4(NAA15):c.228_232del (p.Asp76Glufs)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_057175.4(NAA15):c.228_232del (p.Asp76Glufs)
Variation ID: 446520 Accession: VCV000446520.19
- Type and length
-
Deletion, 5 bp
- Location
-
Cytogenetic: 4q31.1 4: 139336933-139336937 (GRCh38) [ NCBI UCSC ] 4: 140258087-140258091 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Dec 9, 2017 Oct 26, 2024 Nov 9, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_057175.5:c.228_232del MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_476516.1:p.Asp76fs frameshift NM_057175.3:c.228_232del NM_057175.3:c.228_232delCTTGA NC_000004.12:g.139336936_139336940del NC_000004.11:g.140258090_140258094del NG_053037.1:g.40470_40474del - Protein change
- D76fs
- Other names
-
DEL/INS, NT225
- Canonical SPDI
- NC_000004.12:139336932:TGACTTGA:TGA
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
NAA15 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
407 | 452 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (4) |
criteria provided, multiple submitters, no conflicts
|
Jun 8, 2022 | RCV000515798.7 | |
Pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Nov 9, 2023 | RCV000793395.15 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Jun 26, 2018)
|
criteria provided, single submitter
Method: research
|
Intellectual disability, autosomal dominant 50
Affected status: yes
Allele origin:
maternal
|
HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology
Study: AGHI-WGS-HudsonAlpha
Accession: SCV000803186.1 First in ClinVar: Dec 09, 2017 Last updated: Dec 09, 2017 |
Number of individuals with the variant: 1
Clinical Features:
Stereotypy (present) , Sleep disturbance (present) , Self-biting (present) , Skin-picking (present) , Developmental regression (present) , Feeding difficulties (present)
|
|
Pathogenic
(Jun 08, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Intellectual disability, autosomal dominant 50
Affected status: yes
Allele origin:
germline
|
Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center
Accession: SCV002568192.1
First in ClinVar: Sep 03, 2022 Last updated: Sep 03, 2022 |
Comment:
PVS1, PS2, PM2
|
|
Pathogenic
(Mar 11, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000932744.6
First in ClinVar: Aug 14, 2019 Last updated: Feb 14, 2024 |
Comment:
Loss-of-function variants in NAA15 are known to be pathogenic (PMID: 28191889, 29656860). For these reasons, this variant has been classified as Pathogenic. This variant has … (more)
Loss-of-function variants in NAA15 are known to be pathogenic (PMID: 28191889, 29656860). For these reasons, this variant has been classified as Pathogenic. This variant has been observed in an individual affected with autism spectrum disorder (PMID: 28191889). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Asp76Glufs*20) in the NAA15 gene. It is expected to result in an absent or disrupted protein product. (less)
|
|
Pathogenic
(Nov 09, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV001983272.4
First in ClinVar: Oct 30, 2021 Last updated: Oct 08, 2024 |
Comment:
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not … (more)
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28191889, 33004838, 35710456, 29656860) (less)
|
|
Pathogenic
(Jul 07, 2021)
|
no assertion criteria provided
Method: literature only
|
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 50, WITH BEHAVIORAL ABNORMALITIES
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000611895.2
First in ClinVar: Dec 09, 2017 Last updated: Jul 10, 2021 |
Comment on evidence:
In a male patient (patient 11, AGRE_03C14733) with autosomal dominant intellectual developmental disorder-50 with behavioral abnormalities (MRD50; 617787) manifest as autism spectrum disorder, Stessman et … (more)
In a male patient (patient 11, AGRE_03C14733) with autosomal dominant intellectual developmental disorder-50 with behavioral abnormalities (MRD50; 617787) manifest as autism spectrum disorder, Stessman et al. (2017) identified a de novo heterozygous del/ins mutation (c.225_230delTGACTTinsT, NM_057175.3) in the NAA15 gene, resulting in a frameshift and premature termination (Asp76GlufsTer20). (less)
|
|
Likely pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Accession: SCV002522461.1
First in ClinVar: Jun 05, 2022 Last updated: Jun 05, 2022 |
|
|
Likely pathogenic
(Jun 01, 2022)
|
no assertion criteria provided
Method: provider interpretation
|
Intellectual disability, autosomal dominant 50
Affected status: yes
Allele origin:
inherited
|
Solve-RD Consortium
Accession: SCV005200055.1
First in ClinVar: Oct 26, 2024 Last updated: Oct 26, 2024
Comment:
Variant identified during reanalysis of unsolved cases by the Solve-RD project. The Solve-RD project has received funding from the European Union’s Horizon 2020 research and … (more)
Variant identified during reanalysis of unsolved cases by the Solve-RD project. The Solve-RD project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 779257. (less)
|
Comment:
Variant confirmed as disease-causing by referring clinical team
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies. | Cheng H | American journal of human genetics | 2018 | PMID: 29656860 |
Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases. | Stessman HA | Nature genetics | 2017 | PMID: 28191889 |
Text-mined citations for rs1380822792 ...
HelpRecord last updated Oct 27, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.